As of 2025-07-09, the Intrinsic Value of Global Bio-chem Technology Group Co Ltd (809.HK) is 13.76 HKD. This 809.HK valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.09 HKD, the upside of Global Bio-chem Technology Group Co Ltd is 15,531.60%.
The range of the Intrinsic Value is 11.34 - 19.14 HKD
Based on its market price of 0.09 HKD and our intrinsic valuation, Global Bio-chem Technology Group Co Ltd (809.HK) is undervalued by 15,531.60%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 11.34 - 19.14 | 13.76 | 15531.6% |
| DCF (Growth 10y) | 8.87 - 11.48 | 9.71 | 10933.1% |
| DCF (EBITDA 5y) | 7.08 - 7.35 | 7.18 | 8064.3% |
| DCF (EBITDA 10y) | 8.12 - 8.79 | 8.40 | 9450.0% |
| Fair Value | 0.43 - 0.43 | 0.43 | 393.38% |
| P/E | 0.56 - 1.06 | 0.69 | 689.6% |
| EV/EBITDA | (0.60) - 0.14 | (0.29) | -426.0% |
| EPV | 0.07 - 0.45 | 0.26 | 196.2% |
| DDM - Stable | 0.18 - 0.47 | 0.33 | 273.8% |
| DDM - Multi | 0.12 - 0.32 | 0.19 | 112.2% |
| Market Cap (mil) | 779.93 |
| Beta | -0.31 |
| Outstanding shares (mil) | 8,862.85 |
| Enterprise Value (mil) | 4,385.50 |
| Market risk premium | 5.98% |
| Cost of Equity | 25.28% |
| Cost of Debt | 5.50% |
| WACC | 8.82% |